Side Effects of Breast Cancer Drugs Ibrance, Kisqali, Verzenio May Cause Lung Inflammation: FDA
The FDA has placed new warning labels on the breast cancer drugs Ibrance, Kisqali and Verzenio, which have been linked to rare cases of severe lung inflammation.